Cost EffectivenessGenetic TestingBreast CancerBackground: Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer.Koldehoff, AndreasUniv Hosp Cologne AoRDanner, MarionFac MedCivello, DanieleRhiem, KerstinStock, StephanieMueller, Dirk...
Women at risk for a genetic breast cancer disorder must understand what the genetic testing process involves. First, an expert reviews the family medical history to evaluate what sort of pattern of genetic breast cancer may be occurring. Next, the family member'stumorsample, if available, undergo...
The projectedcost savingsin the new study are based on two factors: about a 50 percent increased cost ingene testingassuming that it will be done for all newly diagnosed women, which would be offset by an approximately 8 percent expected drop in the overall cost of chemotherapy due to fewer ...
doi:10.1001/jamanetworkopen.2023.56078 Key Points Question Is a population-wide genetic testing strategy more cost-effective than the current family history–based testing strategy for breast and ovarian cancer prevention? Findings This economic evaluation found that population-based BRCA1, BRCA2, and ...
To examine the relative cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer provided by Genetic Services of Western Australia. The relative cost-effectiveness was assessed using a decision analytic model. The cost and outcomes of genetic testing was compared in first-...
Further research to decrease the frequency of inconclusive results could improve the cost-effectiveness of this test. 展开 关键词: BRCA breast cancer cost-effectiveness genetic testing DOI: 10.1111/j.1524-4733.2008.00418.x 被引量: 52 年份: 2009 ...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relatives. There are various guidelines and consensus stat...
genetic testing has been recommended to identify carriers who would benefit from cancer prevention interventions.13,14Given the high cost of the test and the potentially large number needed to test to detect a mutation, though, there has been an increasing interest in the cost-effectiveness ofBRCA...
"I wish genetic testing was the standard of care," said Carbary, who owed nothing for the test because her insurer covered the cost. Carbary, who lives in Sterling Heights, Michigan, said the test results affirmed the decision she had already made to have a double mastectomy and provided im...
Two separate dependent variables were used as measures for intention to obtain BRCA testing: (1) "I plan to have a genetic test for breast cancer only if my insurance covers the cost"; and (2) "I plan to have a genetic test for breast cancer, even if I have to pay for it myself...